Staining for anti-MUC1 monoclonal antibodies in tumour cells of ALK positive systemic nodal anaplastic large cell lymphoma
| Case | SM3 | VU–4H5 | DF3 | 139H2 | E29 |
|---|---|---|---|---|---|
| +++, 75–95% positive tumour cells; ++, 50–75% positive tumour cells; +, 25–50% positive tumour cells; +/–, focal or scattered staining of <25% of tumour cells; –, no staining of tumour cells. | |||||
| 1 | – | – | – | – | – |
| 2 | – | – | +++ | +++ | +++ |
| 3 | – | ++ | +++ | ++ | +++ |
| 4 | – | +/– | +++ | ++ | +++ |
| 5 | – | – | +++ | + | +++ |
| 6 | – | – | +++ | +++ | +++ |
| 7 | – | +++ | +++ | +++ | +++ |
| 8 | – | – | +++ | ++ | +++ |
| 9 | – | – | +/– | +/– | +/– |
| 10 | – | ++ | +++ | +++ | +++ |
| 11 | – | +/– | ++ | + | ++ |
| 12 | – | – | +++ | +++ | +++ |
| 13 | – | – | +/– | +/– | +/– |
| 14 | – | – | +++ | +++ | +++ |
| 15 | – | – | – | – | – |
| 16 | – | – | +++ | ++ | +++ |
| 17 | – | + | +++ | ++ | +++ |